Clinical Trials Browser

OTHER × Central Nervous System Neoplasms × Lenalidomide × Clear all

NCT04446962 2025-09-25

LOC-R01

Phase 1/2 Active not recruiting

Lymphoma, Neurologic Manifestations, Lymphoma, Large B-Cell, Diffuse, Central Nervous System Neoplasms

NCT03050450 2021-04-05

Study of Lenalidomide With Vorinostat in Pediatric Patients With High Grade or Progressive CNS Tumors

Phase 1 Terminated

8 enrolled 10 charts

Central Nervous System Neoplasms